ArticleBritish journal of cancer2012

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells.

T Troiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.